These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. New organoruthenium compounds with pyrido[2',3':5,6]pyrazino[2,3-f][1, 10]phenanthroline: synthesis, characterization, cytotoxicity, and investigation of mechanism of action. Pavlović M; Nikolić S; Gligorijević N; Dojčinović B; Aranđelović S; Grgurić-Šipka S; Radulović S J Biol Inorg Chem; 2019 Mar; 24(2):297-310. PubMed ID: 30762123 [TBL] [Abstract][Full Text] [Related]
26. Anticancer activity of tetracationic arene ruthenium metalla-cycles. Barry NP; Edafe F; Therrien B Dalton Trans; 2011 Jul; 40(27):7172-80. PubMed ID: 21660364 [TBL] [Abstract][Full Text] [Related]
27. Imine-N-Heterocyclic Carbenes as Versatile Ligands in Ruthenium(II) p-Cymene Anticancer Complexes: A Structure-Activity Relationship Study. Yang Y; Guo L; Tian Z; Liu X; Gong Y; Zheng H; Ge X; Liu Z Chem Asian J; 2018 Oct; 13(19):2923-2933. PubMed ID: 30101417 [TBL] [Abstract][Full Text] [Related]
28. From hydrolytically labile to hydrolytically stable Ru(II)-arene anticancer complexes with carbohydrate-derived co-ligands. Hanif M; Meier SM; Kandioller W; Bytzek A; Hejl M; Hartinger CG; Nazarov AA; Arion VB; Jakupec MA; Dyson PJ; Keppler BK J Inorg Biochem; 2011 Feb; 105(2):224-31. PubMed ID: 21194622 [TBL] [Abstract][Full Text] [Related]
34. New π-arene ruthenium(II) piano-stool complexes with nitrogen ligands. Grau J; Noe V; Ciudad C; Prieto MJ; Font-Bardia M; Calvet T; Moreno V J Inorg Biochem; 2012 Apr; 109():72-81. PubMed ID: 22387934 [TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization, antimicrobial and cytotoxic activity of novel half-sandwich Ru(II) arene complexes with benzoylthiourea derivatives. Obradović D; Nikolić S; Milenković I; Milenković M; Jovanović P; Savić V; Roller A; Đorđić Crnogorac M; Stanojković T; Grgurić-Šipka S J Inorg Biochem; 2020 Sep; 210():111164. PubMed ID: 32634653 [TBL] [Abstract][Full Text] [Related]
36. Comparative solution equilibrium studies of antitumor ruthenium(η Dömötör O; Pape VFS; May NV; Szakács G; Enyedy ÉA Dalton Trans; 2017 Mar; 46(13):4382-4396. PubMed ID: 28287667 [TBL] [Abstract][Full Text] [Related]
37. Synthesis, characterization, and anticancer activity of a series of ketone-N(4)-substituted thiosemicarbazones and their ruthenium(II) arene complexes. Su W; Qian Q; Li P; Lei X; Xiao Q; Huang S; Huang C; Cui J Inorg Chem; 2013 Nov; 52(21):12440-9. PubMed ID: 24143913 [TBL] [Abstract][Full Text] [Related]
38. Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages. Dubey A; Park DW; Kwon JE; Jeong YJ; Kim T; Kim I; Kang SC; Chi KW Int J Nanomedicine; 2015; 10 Spec Iss(Spec Iss):227-40. PubMed ID: 26366074 [TBL] [Abstract][Full Text] [Related]
39. Ruthenium(II) p-cymene complex bearing 2,2'-dipyridylamine targets caspase 3 deficient MCF-7 breast cancer cells without disruption of antitumor immune response. Kaluđerović GN; Krajnović T; Momcilovic M; Stosic-Grujicic S; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E J Inorg Biochem; 2015 Dec; 153():315-321. PubMed ID: 26428537 [TBL] [Abstract][Full Text] [Related]
40. Experimental and theoretical investigations of cyclometalated ruthenium(ii) complex containing CCC-pincer and anti-inflammatory drugs as ligands: synthesis, characterization, inhibition of cyclooxygenase and in vitro cytotoxicity activities in various cancer cell lines. Tabrizi L; Olasunkanmi LO; Fadare OA Dalton Trans; 2019 Jan; 48(2):728-740. PubMed ID: 30560261 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]